"We’re in this with you, to help you get the care you need, safely. Vanderbilt Health has restarted surgeries, procedures and clinic visits that were paused or delayed. Safety is our top priority, with measures that follow – and in some cases exceed – local, state and CDC public health recommendations. Everyone wears a mask – patients, visitors, doctors, nurses and staff. We’re sanitizing rooms between each patient, and cleaning public spaces frequently throughout the day. We’re checking everyone for fever and symptoms before they enter our facilities. We’ve spaced chairs in waiting areas, limited the number who can ride elevators at once and made other changes so we can keep a safe (6 feet) physical distance."

During the past decade, Vanderbilt-Ingram Cancer Center - Cool Springs conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 34 clinical trials were completed, i.e. on average, 72.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 20 clinical trials were completed. i.e. 181.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center - Cool Springs" #1 sponsor was "Vanderbilt-Ingram Cancer Center" with 36 trials, followed by "National Cancer Institute (NCI)" with 32 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "Vanderbilt University" with 16 trials sponsored and "Vanderbilt University Medical Center" with 16 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center - Cool Springs" #1 collaborator was "National Cancer Institute (NCI)" with 93 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt-Ingram Cancer Center - Cool Springs" are "Head and Neck Cancer" (19 trials), "Breast Cancer" (15 trials), "Lung Cancer" (11 trials), "Colorectal Cancer" (8 trials) and "Invasive Breast Carcinoma" (8 trials). Many other conditions were trialed in "Vanderbilt-Ingram Cancer Center - Cool Springs" in a lesser frequency.

Most popular intervention types in "Vanderbilt-Ingram Cancer Center - Cool Springs" are "Other" (85 trials), "Drug" (73 trials), "Procedure" (47 trials), "Biological" (35 trials) and "Genetic" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "laboratory biomarker analysis" (19 trials), "medical chart review" (14 trials), "Biospecimen Collection" (12 trials) and "Quality-of-Life Assessment" (12 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt-Ingram Cancer Center - Cool Springs" are 113 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Vanderbilt-Ingram Cancer Center - Cool Springs". undefined are not yet recruiting, 15 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Vanderbilt-Ingram Cancer Center - Cool Springs, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt-Ingram Cancer Center - Cool Springs, 9 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".